Division of Hematology and Oncology Archive — Page 14 of 16
-
March 3, 2016
Melanoma response to immune therapy
Melanoma-specific expression of a certain protein identifies tumors that are more responsive to an immune therapy. -
March 3, 2016
First VICC cancer patient treated with new immunotherapy
For the first time, Vanderbilt-Ingram Cancer Center (VICC) investigators have used a cancer patient’s own re-engineered immune cells to treat a form of blood cancer by stimulating the immune system. -
January 21, 2016
Lovly lands cancer research grant from V Foundation
Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology, has been awarded a V Scholar Grant from the V Foundation for Cancer Research. -
January 14, 2016
VICC helps expand cancer patient’s treatment options
Edward (Ned) Wikle recently celebrated the Christmas holidays with his wife and three young children, a celebration the Jackson, Mississippi-based endodontist, U.S. Navy veteran and cancer patient wasn’t sure he would have. -
December 10, 2015
VICC’s Balko named a Susan G. Komen ‘Pink Tie Guy’
Justin Balko, Pharm.D., Ph.D., assistant professor of Medicine and Cancer Biology, has been named a member of the 2016 class of Pink Tie Guys by the Greater Nashville Affiliate of Susan G. Komen, a nonprofit organization dedicated to breast cancer research and patient support. -
August 13, 2015
Rathmell to direct Division of Hematology and Oncology
W. Kimryn Rathmell, M.D., Ph.D., Alexander Professor for Translational Science and associate director for Training and Education at Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, has been named director of Vanderbilt’s Division of Hematology and Oncology. -
July 16, 2015
Kitko to lead Pediatric Stem Cell Transplant Program
Carrie Kitko, M.D., has joined Monroe Carell Jr. Children’s Hospital at Vanderbilt as associate professor of Pediatrics and director of the Pediatric Stem Cell Transplant Program in the Division of Hematology/Oncology.